Existing GLP-1 receptor agonist therapies like semaglutide or the peptide Amylin analogue Pramlintide have limited impact due to high costs, accessibility, and undesirable side effects.

Medically reviewed by Lindsay Cook, PharmD Type 2 diabetes is a form of diabetes characterized by high blood sugar (glucose), ...